118 related articles for article (PubMed ID: 32623829)
1. Nuclear staining of claudin-18 is a new immunohistochemical marker for diagnosing intramucosal well-differentiated gastric adenocarcinoma.
Takahashi Y; Tsutsumi Y; Takeuchi C; Shiogama K; Mizutani Y; Inada KI; Yamamichi N; Koike K
Pathol Int; 2020 Sep; 70(9):644-652. PubMed ID: 32623829
[TBL] [Abstract][Full Text] [Related]
2. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
3. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
4. The distinct expression patterns of claudin-10, -14, -17 and E-cadherin between adjacent non-neoplastic tissues and gastric cancer tissues.
Gao M; Li W; Wang H; Wang G
Diagn Pathol; 2013 Dec; 8():205. PubMed ID: 24325792
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
[TBL] [Abstract][Full Text] [Related]
6. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
7. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):230-7. PubMed ID: 12966349
[TBL] [Abstract][Full Text] [Related]
8. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
9. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
11. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of claudin-3 is associated with proliferative potential in early gastric cancers.
Okugawa T; Oshima T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Matsumoto T; Miwa H
Dig Dis Sci; 2012 Jun; 57(6):1562-7. PubMed ID: 22290341
[TBL] [Abstract][Full Text] [Related]
13. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas.
Rendón-Huerta E; Teresa F; Teresa GM; Xochitl GS; Georgina AF; Veronica ZZ; Montaño LF
J Gastrointest Cancer; 2010 Mar; 41(1):52-9. PubMed ID: 19960275
[TBL] [Abstract][Full Text] [Related]
14. Tubular adenoma and intramucosal intestinal-type adenocarcinoma of the stomach: what are the pathobiological differences?
Kase S; Osaki M; Honjo S; Adachi H; Ito H
Gastric Cancer; 2003; 6(2):71-9. PubMed ID: 12861397
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
[TBL] [Abstract][Full Text] [Related]
16. [Еxpression of claudin-1, 3, and 4 in colorectal cancer and polyps].
Nefedova NА; Kharlova ОА; Malkov PG
Arkh Patol; 2016; 78(3):11-19. PubMed ID: 27296001
[TBL] [Abstract][Full Text] [Related]
17. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
Li WT; Jeng YM; Yang CY
Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
[TBL] [Abstract][Full Text] [Related]
18. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
19. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype.
Soini Y; Tommola S; Helin H; Martikainen P
Virchows Arch; 2006 Jan; 448(1):52-8. PubMed ID: 16220299
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
